Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Salgia

Showing results (71-80 of 77) with videos related to

Pageof 8
Sort By:
You have reached the last page of results.This site can display upto 77 results.
The Journal of Biological Chemistry|February 14, 1997
Involvement of p130(Cas) and p105(HEF1), a novel Cas-like docking protein, in a cytoskeleton-dependent signaling pathway initiated by ligation of integrin or antigen receptor on human B cellsS N Manié, A R Beck, A Astier, et al.
Oncogene|February 2, 1999
Expression of the focal adhesion protein paxillin in lung cancer and its relation to cell motilityR Salgia, J L Li, D S Ewaniuk, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|May 23, 2015
A randomized phase II study of ganetespib, a heat shock protein 90 inhibitor, in combination with docetaxel in second-line therapy of advanced non-small cell lung cancer (GALAXY-1)S Ramalingam, G Goss, R Rosell, et al.
Blood|December 10, 1999
The BCR/ABL oncogene alters the chemotactic response to stromal-derived factor-1alphaR Salgia, E Quackenbush, J Lin, et al.
Oral Oncology|March 16, 2013
Oral cavity tumors in younger patients show a poor prognosis and do not contain viral RNAJ Brägelmann, I Dagogo-Jack, M El Dinali, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 24, 2016
Selumetinib with and without erlotinib in KRAS mutant and KRAS wild-type advanced nonsmall-cell lung cancerC A Carter, A Rajan, C Keen, et al.
Oncogene|November 19, 2008
Disruption of the EGFR E884-R958 ion pair conserved in the human kinome differentially alters signaling and inhibitor sensitivityZ Tang, S Jiang, R Du, et al.
Pageof 8

Showing results (71-80 of 77) with videos related to

Sort By:
Pageof 8
You have reached the last page of results.This site can display upto 77 results.
The Journal of Biological Chemistry|February 14, 1997
Involvement of p130(Cas) and p105(HEF1), a novel Cas-like docking protein, in a cytoskeleton-dependent signaling pathway initiated by ligation of integrin or antigen receptor on human B cellsS N Manié, A R Beck, A Astier, et al.
Oncogene|February 2, 1999
Expression of the focal adhesion protein paxillin in lung cancer and its relation to cell motilityR Salgia, J L Li, D S Ewaniuk, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|May 23, 2015
A randomized phase II study of ganetespib, a heat shock protein 90 inhibitor, in combination with docetaxel in second-line therapy of advanced non-small cell lung cancer (GALAXY-1)S Ramalingam, G Goss, R Rosell, et al.
Blood|December 10, 1999
The BCR/ABL oncogene alters the chemotactic response to stromal-derived factor-1alphaR Salgia, E Quackenbush, J Lin, et al.
Oral Oncology|March 16, 2013
Oral cavity tumors in younger patients show a poor prognosis and do not contain viral RNAJ Brägelmann, I Dagogo-Jack, M El Dinali, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 24, 2016
Selumetinib with and without erlotinib in KRAS mutant and KRAS wild-type advanced nonsmall-cell lung cancerC A Carter, A Rajan, C Keen, et al.
Oncogene|November 19, 2008
Disruption of the EGFR E884-R958 ion pair conserved in the human kinome differentially alters signaling and inhibitor sensitivityZ Tang, S Jiang, R Du, et al.
Pageof 8